ReViral raised €37M in a Series C round in Aug 2020. The company is based in Stevenage, UK. Investors in the round: CR-CP Life Science Fund. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
